Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 11/20 | 1.00 |
| ▸ | CYBB | P04839 | 2/20 | 1.00 |
| ▸ | NOX3 | Q9HBY0 | 2/20 | 1.00 |
| ▸ | NOX4 | Q9NPH5 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 8/20 | 0.61 |
| ▸ | GAA | P10253 | 6/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | SNCA | P37840 | 3/20 | 0.59 |
| ▸ | BCHE | P06276 | 2/20 | 0.59 |
| ▸ | ACHE | P22303 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenothiazine SCHEMBL6532335 | 1.00 | NOX1 (1.00) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL29475150 | 1.00 | NOX1 (1.00) | NOX1CYBBNOX3NOX4MAPT | |
| Benzene SCHEMBL29242186 | 0.98 | NOX1 (0.97) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL10372692 | 0.91 | NOX1 (0.84) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL30811565 | 0.91 | NOX1 (0.84) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL1855582 | 0.91 | NOX1 (0.83) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL25898787 | 0.83 | NOX1 (0.71) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL11375009 | 0.82 | NOX1 (0.69) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL8881132 | 0.82 | NOX1 (0.68) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL9007359 | 0.82 | NOX1 (0.68) | NOX1CYBBNOX3NOX4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255879-A1 | PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER COMPRISING NUPR1 ISOFORM A INHIBITOR | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-08-14 | — | — | US | claimed |
| US-20230330095-A1 | PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER COMPRISING NUPR1 ISOFORM A INHIBITOR | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2023-10-19 | — | — | US | claimed |
| EP-4260861-A1 | PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER COMPRISING NUPR1 ISOFORM A INHIBITOR | Seoul National University R & DB Foundation (KR) | 2023-10-18 | — | — | EP | claimed |
| CN-108484816-B | Phenothiazine drug family specific molecularly imprinted polymer, chemiluminescence kit and detection method | 河北农业大学 | 2020-11-06 | — | — | CN | claimed |
| CN-107406796-B | Lubricant for refrigerator and mixed composition for refrigerator | 出光兴产株式会社 | 2020-10-16 | — | — | CN | claimed |
| EP-3279296-B1 | REFRIGERATOR LUBRICATING OIL AND MIXED COMPOSITION FOR REFRIGERATOR | IDEMITSU KOSAN CO (JP) | 2020-04-29 | — | — | EP | claimed |
| US-10544380-B2 | Refrigerator lubricating oil and mixed composition for refrigerator | IDEMITSU KOSAN CO., LTD. (JP) | 2020-01-28 | — | — | US | claimed |
| US-20180057766-A1 | REFRIGERATOR LUBRICATING OIL AND MIXED COMPOSITION FOR REFRIGERATOR | IDEMITSU KOSAN CO., LTD. (JP) | 2018-03-01 | — | — | US | claimed |
| EP-3279296-A1 | REFRIGERATOR LUBRICATING OIL AND MIXED COMPOSITION FOR REFRIGERATOR | Idemitsu Kosan Co. Ltd (IKC) (JP) | 2018-02-07 | — | — | EP | claimed |
| US-20170043196-A1 | Fire Extinguishing Composition Comprising Heterocyclic Compounds | XI'AN J&R FIRE FIGHTING EQUIPMENT CO., LTD. (CN) | 2017-02-16 | — | — | US | claimed |
| EP-3095485-A1 | FIRE EXTINGUISHING COMPOSITION COMPRISING HETEROCYCLIC COMPOUNDS | Xi'an J&R Fire Fighting Equipment Co., Ltd. (CN) | 2016-11-23 | — | — | EP | claimed |
| CN-105153062-A | Preparation method of permitil | JIANGSU BAOZONG & BAODA PHARMACHEM CO LTD | 2015-12-16 | — | — | CN | claimed |
| CN-102690245-A | Method for preparing trifluoperazine hydrochloride | TAICANG HENGYI MEDICAL CHEMICAL RAW MATERIALS PLANT | 2012-09-26 | — | — | CN | claimed |
| US-7897311-B2 | Phenothiazine containing photogenerating layer photoconductors | XEROX CORPORATION (US) | 2011-03-01 | — | — | US | claimed |
| US-7615312-B2 | Electrolytic cells; phenothiazine compound has oxidation potential above positive electrode recharged potential and serves as cyclable redox chemical shuttle providing cell overcharge protection | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-11-10 | — | — | US | claimed |
| US-20090274969-A1 | PHENOTHIAZINE CONTAINING PHOTOGENERATING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-11-05 | — | — | US | claimed |
| EP-1883987-A1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M Innovative Properties Company (US) | 2008-02-06 | — | — | EP | claimed |
| WO-2006124738-A1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-11-23 | — | — | WO | claimed |
| US-20060263697-A1 | Substituted phenothiazine redox shuttles for rechargeable lithium-ion cell | 3M INNOVATIVE PROPERTIES COMPANY | 2006-11-23 | — | — | US | claimed |
| US-4249003-A | Process for polycyclic amines | AKTIEBOLAGET LEO (SE) | 1981-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230330095-A1 | PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER COMPRISING NUPR1 ISOFORM A INHIBITOR | NUP205, NUP50, NUP188 | NOX1 3666/4885CYBB 4601/4885NOX3 4343/4885 |
| US-20250255879-A1 | PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER COMPRISING NUPR1 ISOFORM A INHIBITOR | NUP205, NUP188, NUP50 | NOX1 3568/4885CYBB 4645/4885NOX3 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.